Sangmin Lee Selected Research

Sangmin Lee Research Topics

Disease

34	Neoplasms (Cancer) 06/2022 - 01/2003
9	Multiple Sclerosis 01/2020 - 06/2011
6	Infections 01/2022 - 08/2018
6	Inflammation (Inflammations) 07/2021 - 09/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 12/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 05/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2011
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2019
2	COVID-19 01/2022 - 12/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2019
2	Female Infertility 06/2021 - 01/2019
2	Spontaneous Abortion (Miscarriage) 06/2021 - 01/2019
2	Stillbirth 06/2021 - 01/2019
2	Premature Birth (Birth, Premature) 06/2021 - 01/2019
2	Crohn Disease (Crohn's Disease) 01/2021 - 05/2018
2	Carcinogenesis 01/2021 - 02/2018
2	Paralysis (Palsy) 04/2020 - 01/2019
2	Pain (Aches) 03/2020 - 01/2019
2	Alcoholic Fatty Liver 10/2019 - 11/2016
2	Brain Neoplasms (Brain Tumor) 01/2017 - 08/2011
2	Rheumatoid Arthritis 10/2016 - 09/2012
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 09/2012 - 11/2008
2	Spinal Cord Diseases 09/2012 - 11/2008
2	Paraplegia (Spastic Paraplegia) 01/2012 - 06/2011
1	Birth Weight (Birth Weights) 12/2022
1	Corneal Injuries 10/2022
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 10/2022
1	Pneumonia (Pneumonitis) 10/2022
1	Keratitis 10/2022
1	Tetanus 01/2022
1	Diphtheria 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Whooping Cough (Pertussis) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Substance-Related Disorders (Drug Abuse) 09/2021
1	Skin Diseases (Skin Disease) 07/2021
1	Contact Dermatitis (Eczema, Contact) 07/2021
1	Atopic Dermatitis (Atopic Eczema) 07/2021
1	Necrosis 01/2021

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2021 - 10/2012
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
8	glycol-chitosanIBA 10/2017 - 08/2011
6	Biological ProductsIBA 01/2022 - 03/2014
6	AntibodiesIBA 01/2020 - 06/2011
5	CytokinesIBA 07/2021 - 01/2013
5	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2020 - 01/2012
4	LipidsIBA 10/2022 - 06/2012
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 01/2014
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2013
4	LigandsIBA 12/2017 - 11/2013
4	AzidesIBA 12/2017 - 03/2014
3	AntigensIBA 01/2022 - 06/2013
3	Peptides (Polypeptides)IBA 10/2021 - 01/2017
3	Polysaccharides (Glycans)IBA 05/2021 - 11/2016
3	Drug CarriersIBA 10/2017 - 06/2012
3	AutoantibodiesIBA 01/2017 - 06/2013
3	CopperIBA 10/2016 - 11/2012
2	VaccinesIBA 01/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 12/2021 - 11/2008
2	EnzymesIBA 12/2021 - 10/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 03/2020 - 01/2019
2	Caspase 3 (Caspase-3)IBA 12/2019 - 11/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2019 - 01/2013
2	Cathepsin BIBA 01/2019 - 11/2016
2	PolymersIBA 03/2018 - 10/2012
2	Liposomes (Liposome)IBA 12/2017 - 06/2012
2	CollagenIBA 10/2017 - 10/2016
2	Coloring Agents (Dyes)IBA 11/2016 - 11/2012
2	RNA (Ribonucleic Acid)IBA 01/2012 - 06/2011
1	Protein Kinases (Protein Kinase)IBA 10/2022
1	resolvin D1IBA 10/2022
1	fascinIBA 06/2022
1	AdrenomedullinIBA 01/2022
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	Nucleic AcidsIBA 12/2021
1	ImmunosorbentsIBA 12/2021
1	Nucleocapsid ProteinsIBA 12/2021
1	Immunoglobulin M (IgM)IBA 12/2021
1	Claudin-4IBA 10/2021
1	Clostridium enterotoxinIBA 10/2021
1	polysialic acidIBA 10/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2021
1	ChemokinesIBA 07/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2021
1	Dinitrochlorobenzene (DNCB)IBA 07/2021
1	Interferon-gamma (Interferon, gamma)IBA 07/2021
1	BilirubinIBA 01/2021

Therapy/Procedure

18	Therapeutics 10/2021 - 01/2011
4	Drug Therapy (Chemotherapy) 10/2021 - 01/2019
4	Intravenous Injections 12/2017 - 12/2013
2	Cesarean Section (Caesarean Section) 06/2021 - 01/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020 - 01/2019
1	Length of Stay 12/2022
1	Biological Therapy 01/2022
1	Self-Testing 01/2022
1	Personal Protective Equipment 12/2021